Compugen (CGEN) Tops Q2 EPS by 1c

Compugen (NASDAQ: CGEN) reported Q2 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• Virax Biolabs announces 1-for-25 reverse stock split on Nasdaq
• Benchmark Reiterates Buy Rating on Cineverse (CNVS) Ahead of Q4 Results